Lessons From Practicing at the PTAB
Thursday, January 14th at 10:30 am United States (GMT -07:00) Pacific
Speaker: Deborah Sterling, Director at Sterne, Kessler, Goldstein & Fox
Inter partes review (IPR), post-grant review (PGR), and covered business method (CBM) procedures are focused, speedy vehicles for resolving unpatentability and § 101 issues. IPRs, especially, are quickly gaining traction as the go-to mechanism for invalidating patents. But with new procedures come new (or not-yet-established) law, and a steep learning curve. This webinar provides insights and lessons learned from the PTAB’s first three years of IPRs, PGRs, and CBMs.
The webinar will last 60 minutes.
This webinar is the second in Patexia's Spotlight on PTAB series, running through March 2016.
Suggested Audience: IP practitioners working with law firms and operating companies, Companies considering using an AIA review to invalidate a patent asserted against them, licensing professionals interested in validity issues
About the Speaker
Dr. Sterling is a Director in the Biotechnology/Chemical Group at Sterne, Kessler, Goldstein & Fox. Her practice is focused in the biotechnology and pharmaceutical industries, where she is involved in all areas of patent procurement, exploitation and enforcement. Dr. Sterling’s experience includes representing clients in approximately 38 inter partes review proceedings, multiple patent interferences and reexaminations, and pharmaceutical and biotechnology patent litigations, including those brought under the Hatch-Waxman Act.